Showing results filtered by:
3 Results
Explanation of two strategies under study for HIV viral eradication from NIAID.
Last Reviewed: March 26, 2019
Kirk Druey, M.D., is the Chief of the Lung and Vascular Inflammation Section (LVIS). The LVIS conducts broad and in-depth translational research that focuses on fundamental processes underlying allergic inflammation. Our research program includes studies aimed at mechanistic dissection of fungal associated-asthma and exploration of the pathogenesis of the rare vascular disorder resembling systemic anaphylaxis, a condition known as systemic capillary leak syndrome (SCLS, Clarkson disease)
Last Reviewed: July 12, 2022
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), reaffirms our commitment to developing safe and effective medical tools against malaria, and, in the words of this years World Malaria Day theme, Harnessing innovation to reducing the malaria disease burden and saving lives.
Published: April 25, 2022